Pitney Bowes vs NCR Voyix
PBI and VYX side by side, both in computer and office equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PBI and VYX compare
Pitney Bowes is the larger company, worth 1.5 times as much as NCR Voyix ($2.1B against $1.4B).
On earnings, Pitney Bowes is cheaper: it trades at 12.1× trailing earnings, against 15.4× for NCR Voyix.
Pitney Bowes grew revenue faster over the last twelve months (−3.5% versus −8.6% for NCR Voyix).
Pitney Bowes keeps more of each dollar of sales as profit, with a net margin of 10.1% compared with 4.9% at NCR Voyix.
Pitney Bowes pays a dividend yielding 1.9%; NCR Voyix does not pay one.
Pitney Bowes scores higher on the StockData Score (13 against 10 for NCR Voyix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PBI | VYX |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $1.4B |
| Share price | $15.59 | $10.48 |
| Change, 1 year | 66.7% | −6.3% |
| Change, 5 years | 109% | −74.3% |
| Beta (5Y) | 1.34 | 1.26 |
| Employees | 6,600 | 14K |
| StockData Score | ||
| Total score | 13 (better) | 10 |
| Valuation score | 5 | 6 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 2 | 2 |
| Health score | 1 | 2 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 12.1× (better) | 15.4× |
| P/S | 1.1× | 0.6× (better) |
| P/B | – | 1.5× |
| EV/EBITDA | – | 8.3× |
| P/FCF | 4.2× | – |
| PEG | 0.21 | – |
| FCF yield | 23.9% (better) | −1.7% |
| Fair value | $22.84 | $21.12 |
| Margin of safety | 31.7% | 50.4% (better) |
| Growth | ||
| Revenue growth (TTM) | −3.5% (better) | −8.6% |
| Revenue growth, 5Y average | −11.8% (better) | −15.4% |
| Net income growth (TTM) | 135% | – |
| EPS growth (TTM) | 187% | – |
| Profitability | ||
| Operating margin | – | 2.4% |
| Net margin | 10.1% (better) | 4.9% |
| FCF margin | 27.1% (better) | −1.00% |
| Return on equity | – | 13.2% |
| Return on invested capital | – | 3.3% |
| Financial health | ||
| Debt / equity | – | 1.16 |
| Net debt / EBITDA | – | 3.01 |
| Interest coverage | – | 0.9× |
| Current ratio | 0.70 | 1.11 (better) |
| Altman Z-score | 2.05 (better) | 1.26 |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | – |
| Payout ratio | 29.1% | – |
| Years of dividend growth | 1 | – |
| Dividend growth, 5Y average | 8.4% | – |
| Buyback yield | 15.7% (better) | 2.3% |
| Shareholder yield | 17.6% (better) | 2.3% |
| Ownership | ||
| Held by institutions | 89.9% | 117% |
| Held by insiders | 5.6% | 0.79% |
| Insider net buying, 12 months | −$92.3M | −$105K (better) |
| Short interest, % of float | 14.9% | – |
Go deeper
- PBI stock overview
- PBI income statement
- PBI valuation and score
- VYX stock overview
- VYX income statement
- VYX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.